Among the ALK-positive ALCL patients, approximately 80% harbor the t(2;5)(p23;q35) translocation [4], causing the expression of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK). The gene discussed is NPM1; the disease is anaplastic large cell lymphoma.